DNA损伤应答在前列腺癌形成、进展和治疗中的作用
本综述总结了DNA损伤应答(DDR)通路改变在前列腺癌(PCa)病因和进展中的作用及其对放疗和抗雄激素治疗反应的影响,重点讨论了DDR基因突变对PCa发生和进展的影响及机制,并探讨了靶向DDR通路改变的治疗(如Poly(ADP-ribose) polymerase抑制剂)以及DDR与雄激素受体信号交叉对话的治疗策略。
要点
- DDR通路改变可能在前列腺癌病因和进展中起重要作用。
- DDR改变可影响前列腺癌对放疗和抗雄激素治疗的反应。
- 靶向DDR通路改变的治疗(如PARP抑制剂)及DDR与雄激素受体信号交叉对话为优化治疗组合提供新策略。
核心结论
- 更好地理解DDR改变在前列腺癌中的机制将有助于基于特定疾病特性选择治疗策略,从而改善疾病管理。
研究设计与样本
- 综述总结了当前关于前列腺癌中DDR改变的知识、其对临床干预的潜在影响以及改善前列腺癌管理的前景。
主要发现
- 临床和临床前研究表明DDR通路改变可能在前列腺癌病因和进展中起重要作用。
- 这些改变可影响前列腺癌对放疗和抗雄激素治疗的反应。
- 越来越多的治疗靶向DDR通路改变(如Poly(ADP-ribose) polymerase抑制剂)。
- 新发现的DDR与雄激素受体信号之间的交叉对话为优化治疗组合开辟了新的可能策略。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical and preclinical studies have revealed that alterations in DNA damage response (DDR) pathways may play an important role in prostate cancer (PCa) etiology and progression. These alterations can influence PCa responses to radiotherapy and anti-androgen treatment. The identification of DNA repair gene aberrations in PCa has driven the interest for further evaluation whether these genetic changes may serve as biomarkers for patient stratification. METHODS: In this review, we summarize the current knowledge on DDR alterations in PCa, their potential impact on clinical interventions and prospects for improved management of PCa. We particularly focus on the influence of DDR gene mutations on PCa initiation and progression and describe the underlying mechanisms. RESULTS AND CONCLUSIONS: A better understanding of these mechanisms, will contribute to better disease management as treatment strategies can be chosen based on the specific disease properties, since a growing number of treatments are targeting DDR pathway alterations (such as Poly(ADP-ribose) polymerase inhibitors). Furthermore, the recently discovered crosstalk between the DDR and androgen receptor signaling opens a new array of possible strategies to optimize treatment combinations. We discuss how these recent and ongoing studies will help to improve diagnostic, prognostic and therapeutic approaches for PCa management.
引用
- Zhang W, van Gent DC, Incrocci L, et al. Role of the DNA damage response in prostate cancer formation, progression and treatment. Prostate Cancer Prostatic Dis. 2019. PMID: 31197228. doi:10.1038/s41391-019-0153-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。